Related Experiment Videos
Sacral nerve root stimulation for lower urinary tract dysfunction: overcoming the problem of lead migration
1Department of Urogynaecology, The Royal Women's Hospital, and The Mercy Hospital for Women, Melbourne, Australia. mcarey@netlink.com
BJU International
|December 21, 2000
Summary
A new electrode for sacral neuromodulation showed significantly less lead migration (4 mm vs. 12 mm) compared to the original model. This may improve patient selection for lower urinary tract dysfunction treatment.
Area of Science:
- Urology
- Biomedical Engineering
- Neurosurgery
Background:
- Sacral neuromodulation is used to treat lower urinary tract dysfunction.
- Patient selection for sacral neuromodulation involves trial stimulation of the S3 nerve root.
- Lead migration during trial stimulation can lead to test failures.
Purpose of the Study:
- To compare lead migration between two test electrodes for S3 nerve root stimulation.
- To evaluate the impact of lead migration on patient response to trial stimulation for sacral neuromodulation.
Main Methods:
- Twelve women with refractory lower urinary tract symptoms underwent peripheral nerve evaluation.
- Two electrode models (original and new) were inserted bilaterally into the S3 nerve roots.
- Lead migration was measured using lateral sacral X-rays; patient response was assessed via urodynamics and urinary diaries.
Main Results:
- The new electrode showed significantly less mean migration (4 mm) compared to the original electrode (12 mm) (P = 0.02).
- Ten out of twelve women had a positive response to trial stimulation with the new lead.
- Reduced lead migration may correlate with improved response rates.
Conclusions:
- The new electrode demonstrated reduced lead migration compared to the original model.
- Lower lead migration may contribute to higher success rates in patient selection for sacral neuromodulation.
- The new electrode has the potential to decrease test failures attributed to lead migration.